DaVita Inc.

208 articles with DaVita Inc.

• Extraordinary Nurses at DaVita Kidney Care Honored with DAISY Awards

  5/13/2021

  DaVita Kidney Care announced that 60 of its nephrology nurses were honored with The DAISY Award for Extraordinary Nurses® during National Nurses Week.

• DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology

  5/10/2021

  DaVita Kidney Care announced the expansion of its home kidney care program to include the HomeChoice Claria Automated Peritoneal Dialysis system enabled by Sharesource remote patient monitoring from Baxter International Inc., a global innovator in renal care.

• DaVita Inc. 1st Quarter 2021 Results

  4/29/2021

  For the quarter, diluted earnings per share from continuing operations was $2.09, an increase of 15.5% from the prior year diluted earnings per share from continuing operations and an increase of 14.2% from the prior year adjusted diluted earnings per share from continuing operations.

• DaVita Solidifies Commitment to ESG, Sets 2025 Goals

  4/27/2021

  DaVita Inc. announced its 2025 Environmental, Social and Governance goals and released its new ESG reports, bolstering its commitment to corporate citizenship and helping create healthy communities.

• DaVita Inc. Schedules 1st Quarter 2021 Investor Conference Call

  4/22/2021

  DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, April 29, 2021 , at 5:00 p.m. Eastern Time . The company plans to release its results after market close the same day.

• DaVita Inc. to Participate in the 2021 Barclays Global Healthcare Conference

  3/9/2021

  DaVita Inc. announced that the company will participate in the 2021 Barclays Global Healthcare Conference.

• DaVita Inc. Announces Add-On Offering of $750 Million Senior Notes

  2/24/2021

  DaVita Inc. announced that it has commenced a private add-on offering of $750 million aggregate principal amount of its 4.625% senior notes due June 1, 2030, subject to market and other conditions.

• DaVita Inc. Announces Upsize and Pricing of Add-On Offering of $1 Billion Senior Notes

  2/24/2021

  DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private add-on offering of $750 million aggregate principal amount of its 4.625% senior notes due June 1, 2030 (the "notes").  

• DaVita Inc. 4th Quarter 2020 Results

  2/11/2021

    [11-February-2021]   DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2020. For the full year diluted earnings per share from continuing operations was $6.39 , an increase of 38.9% from the prior year, and adjusted diluted earnings per share from continuing operations was $7.26

• DaVita Inc. Schedules 4th Quarter 2020 Investor Conference Call

  1/29/2021

  DaVita Inc., announced that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 11, 2021, at 5:00 p.m. Eastern Time.

• Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

  1/5/2021

  First-of-its-kind program combines early risk assessment of kidney decline and comprehensive care management to help slow kidney disease progression, improve care coordination and reduce costs

• 14th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life

  11/23/2020

  Event goes virtual in 2020 to raise awareness of kidney health and support global COVID-19 protection efforts

• DaVita Inc. 3rd Quarter 2020 Results

  10/29/2020

  DaVita Inc. (NYSE: DVA) announced financial and operating results for the third quarter ended September 30, 2020. 

• DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call

  10/15/2020

   DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020 , at 5:00 p.m. Eastern Time . The company plans to release its results after market close the same day.    This call is also being webcast and can be accessed at the DaVita IR web pa

• DaVita Announces Final Results Of Self-Tender Offer - Sep 17, 2020

  9/17/2020

  DAVITA INC. announced the final results of its modified "Dutch auction" tender offer for up to $1.0 billion of its common stock at a price per share not less than $77.00 and not more than $88.00, which expired at 12:00 midnight, New York City time, at the end of the day on September 14, 2020.

• DaVita Announces Preliminary Results of Self-Tender Offer - Sep 15, 2020

  9/15/2020

  DAVITA INC. announced the preliminary results of its modified "Dutch auction" tender offer for up to $1.0 billion of its common stock at a price per share of not less than $77.00 and not more than $88.00, which expired at 12:00 midnight, New York City time, at the end of the day on September 14, 2020.

• DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock - Aug 17, 2020

  8/17/2020

  DaVita Inc. announced that it has commenced a modified "Dutch auction" tender offer for shares of its common stock for an aggregate purchase price of up to $1.0 billion at a price per share of not less than $77.00 and not more than $88.00.

• DaVita Expands Initiative to Advance Nursing Education

  8/13/2020

  The "Bridge to Your Dreams" program offers DaVita clinical teammates the opportunity to receive financial support to help them earn nursing degrees

• DaVita Announces Paula A. Price to Join its Board of Directors

  8/11/2020

  DaVita Inc. announced that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020.

• DaVita Inc. Announces Offering of $1.5 Billion Senior Notes

  8/6/2020

  DaVita Inc. announced that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031, subject to market and other conditions.